Cargando…
The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss
Farnesoid X receptor (FXR, NR1H4) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. Since the role of FXR in osteoclast differentiation remains ill-defined, we investigated the biological function of FXR on osteoclastogenesis, using FXR-deficient mice. We dem...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652726/ https://www.ncbi.nlm.nih.gov/pubmed/29100332 http://dx.doi.org/10.18632/oncotarget.20576 |